Quality of life in Tunisian colorectal cancer patients: a cross-sectional study Imtinene BelaidChaimaa Ben MoussaSlim Ben Ahmed Research 30 June 2022 Pages: 2735 - 2742
Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer Han-Yuan LiuFu-Hui WangChang-Hua Zhang Research Open access 01 July 2022 Pages: 2743 - 2756
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma Pengcheng HeHaibo LiuCheng Liu Research 01 July 2022 Pages: 2757 - 2769
In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma Paweł SobczukHuber BątrukPiotr Rutkowski Research 01 July 2022 Pages: 2771 - 2782
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden Lucia LeccisottiDaria MaccoraStefan Hohaus Research Open access 02 July 2022 Pages: 2783 - 2791
Pan-cancer analysis of tumor mutation burden sensitive tumors reveals tumor-specific subtypes and hub genes related to immune infiltration Huan WuHanchu WangYue Chen Research 02 July 2022 Pages: 2793 - 2804
m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma Tao ZhangPing ShengYuting Jiang Research 03 July 2022 Pages: 2805 - 2822
Increased morbidity evaluated on hospital contacts and prescriptions among 100,834 Danish breast cancer survivors Stine Overvad FredslundAgnethe BerglundClaus Højbjerg Gravholt Research 04 July 2022 Pages: 2823 - 2831
Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors George MellgardVaibhav G. PatelChe-Kai Tsao Research 05 July 2022 Pages: 2833 - 2841
Rare benign liver tumors that require differentiation from hepatocellular carcinoma: focus on diagnosis and treatment Laihui LuoTao WangRenfeng Shan Research 05 July 2022 Pages: 2843 - 2854
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents Vicente Escudero-VilaplanaRoberto Collado-BorrellMaría Sanjurjo Research 06 July 2022 Pages: 2855 - 2882
Seroprevalence study prior and post vaccination in cancer patients in principality of Andorra (COVONCO study) Cristina Royo-CebrecosÏa Robert-MontanerSantiago Albiol Research 09 July 2022 Pages: 2883 - 2892
Nurses’ knowledge of chemotherapy-induced neutropenia and its management: a cross-sectional survey Mohammad Al QadireCherry Ann C. BalladAtika Khalaf Research Open access 12 July 2022 Pages: 2893 - 2901
Decision-making by cancer patients and the role of a counselling facility for complementary and alternative medicine: a cohort study Vanessa HackLena JosfeldJens Büntzel Research Open access 11 July 2022 Pages: 2903 - 2913
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients Mehmet Emin ArayiciNazlican KipcakHulya Ellidokuz Research 13 July 2022 Pages: 2915 - 2928
The OUTREACH study: oncologists of German university hospitals in rotation on a palliative care unit—evaluation of attitude and competence in palliative care and hospice T. BierschingA. SchwedaThe OUTREACH Study Group Research Open access 13 July 2022 Pages: 2929 - 2936
Efficacy and safety of immune checkpoint inhibitors in post-TKI NSCLC patients harboring EGFR mutations Si SunChang LiuHui Yu Research 14 July 2022 Pages: 2937 - 2949
Safety and efficacy of pembrolizumab for advanced nonsmall cell lung cancer: before and during the COVID-19 pandemic Doran KsienskiSapna GuptaMary Lesperance Research 14 July 2022 Pages: 2951 - 2961
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer Yusuke InoueNaoki InuiTakafumi Suda Research 14 July 2022 Pages: 2963 - 2974
The prognostic role of the immunohistochemical expression of S100 in meningiomas Felix BehlingChristina FodiJens Schittenhelm Research Open access 15 July 2022 Pages: 2975 - 2985
Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes Chang LuXue-Wu WeiQing Zhou Research Open access 15 July 2022 Pages: 2987 - 2995
Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma Peng LiShuyu CheYongjie Wang Research 15 July 2022 Pages: 2997 - 3007
Contribution of TLR4 to colorectal tumor microenvironment, etiology and prognosis Elise E. CrameSaeed NourmohammadiJoanne M. Bowen Research Open access 16 July 2022 Pages: 3009 - 3021
KNTC1 as a putative tumor oncogene in pancreatic cancer Ling LiuHongwei ChenChangku Jia Research Open access 19 July 2022 Pages: 3023 - 3031
Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study Yubo PiJingshi WangZhao Wang Research 19 July 2022 Pages: 3033 - 3041
Interferon-γ predicts the treatment efficiency of immune checkpoint inhibitors in cancer patients Jing LiuJingtao MaZhanjun Guo Research 19 July 2022 Pages: 3043 - 3050
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol Florian HuemerStefan HechtLukas Weiss Research Open access 21 July 2022 Pages: 3051 - 3064
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study Daniel RoesslerOsman ÖcalNajib Ben Khaled Research Open access 21 July 2022 Pages: 3065 - 3073
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis Diogo Martins-BrancoGuilherme Nader-MartaEvandro de Azambuja Research 22 July 2022 Pages: 3075 - 3080
Differential role of chronic liver diseases on the incidence of cancer: a longitudinal analysis among 248,224 outpatients in Germany Sven H. LoosenDavid SchölerChristoph Roderburg Research Open access 22 July 2022 Pages: 3081 - 3087
AURKA is a prognostic potential therapeutic target in skin cutaneous melanoma modulating the tumor microenvironment, apoptosis, and hypoxia ShengYong LongXuan Fen Zhang Research 23 July 2022 Pages: 3089 - 3107
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience Meerim ParkJun Ah LeeByung Kiu Park Research 23 July 2022 Pages: 3109 - 3119
Epidemiological and clinicopathological analysis of basal cell carcinoma in Egyptian population: a 5-year retrospective multicenter study Mohamed El-KhalawanyHussein M. M. Hassab-El-NabySoha Aboeldahab Research Open access 23 July 2022 Pages: 3121 - 3129
Advantages of organ-sparing treatment approaches in metastatic kidney cancer Iurii VitrukOleg VoylenkoEduard Stakhovsky Research 23 July 2022 Pages: 3131 - 3137
Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer Eiji TakeuchiKensuke KondoYasuhiko Nishioka Research Open access 24 July 2022 Pages: 3139 - 3147
The role of microRNA-30c in targeting interleukin 6, as an inflammatory cytokine, in the mesenchymal stem cell: a therapeutic approach in colorectal cancer Mohamad MahjoorHamed AfkhamiSamaneh Khorrami Research 25 July 2022 Pages: 3149 - 3160
Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma Verena EllerkampAndreas SchmidtJoerg Fuchs Research Open access 25 July 2022 Pages: 3161 - 3170
Prognosis of different extrathoracic metastasis patterns in patients with M1c lung adenocarcinoma receiving immunotherapy Fang HuJin PengLiyan Jiang Research 27 July 2022 Pages: 3171 - 3184
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients Ryoko Inaba HigashiyamaHidehito HorinouchiYuichiro Ohe Research Open access 28 July 2022 Pages: 3185 - 3191
The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition Arthur BauerNiklas GebauerHanno M. Witte Research Open access 28 July 2022 Pages: 3193 - 3208
Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030 Yuan FangZhen LiMing Lu Research 29 July 2022 Pages: 3209 - 3218
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study Na WangYili ZhuXiu Nie Research 29 July 2022 Pages: 3219 - 3228
Breast cancer patient-reported outcomes on level 1 and level 2 oncoplastic procedures using BREAST-Q® C. A. PintoB. PeleteiroJ. L. Fougo Research 29 July 2022 Pages: 3229 - 3241
Incidence of asymptomatic COVID-19 positivity in cancer patients and effects on therapy Lisa LiuNicole M. RossNamrata Vijayvergia Research 29 July 2022 Pages: 3243 - 3247
Real world data on IO-based therapy for metastatic renal cell carcinoma Viktoria StühlerLisa HerrmannJens Bedke Research Open access 30 July 2022 Pages: 3249 - 3258
Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia Huirong MaiQin LiSixi Liu Research 02 August 2022 Pages: 3259 - 3266
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis Benedikt FlörschJulian TaugnerFarkhad Manapov Research Open access 02 August 2022 Pages: 3267 - 3276
Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer Yuki YamadaYoshihisa ShimadaNorihiko Ikeda Research 02 August 2022 Pages: 3277 - 3285
MDFNet: application of multimodal fusion method based on skin image and clinical data to skin cancer classification Qian ChenMin LiCheng Chen Research 03 August 2022 Pages: 3287 - 3299
Uncertainty-aware dynamic integration for multi-omics classification of tumors Ling DuChaoyi LiuJinmiao Chen Research 04 August 2022 Pages: 3301 - 3312